Octapharma

Octapharma is a global pharmaceutical company that develops and manufactures protein-based medicines derived from human plasma and human cell lines. Their product portfolio focuses on therapies for haematology, immunotherapy, and critical care for patients with medical conditions requiring these specialized proteins.

AI named Octapharma in September 2026.